Angela Gallo's team found that editing of the BLCAP transcript was downregulated in astrocytomas, bladder cancer and colorectal cancer [21], while other groups reported a general elevation of editing levels in cancerous tissues such as liver, brain, oral cavity and lung [11, 13]. The gene discussed is BLCAP; the disease is urinary bladder cancer.